MyFinsight
Home
Blog
About
Contact
Download
Download image
Total comprehensive
loss
-$55,827K
Unrealized gain on
marketable securities
$17K
Net loss
-$55,844K
Other income, net
$1,772K
Loss from operations
-$57,616K
Total operating
expenses
$57,616K
Research and development
$44,923K
General and
administrative
$12,693K
Back
Back
Income Statement
source: myfinsight.com
NextCure, Inc. (NXTC)
NextCure, Inc. (NXTC)